Centessa Pharmaceuticals (CNTA) Net Cash Flow (2020 - 2026)
Centessa Pharmaceuticals (CNTA) reported Net Cash Flow of $950000.0 for Q1 2026, up 100.34% year-over-year from $474185.5 in Q1 2025, and down 89.96% quarter-over-quarter from $9.5 million in Q4 2025.
Centessa Pharmaceuticals (CNTA) Net Cash Flow (2020 - 2026) Analysis & Trends
Centessa Pharmaceuticals (CNTA) has 7 years of Net Cash Flow data on file, last reported at $950000.0 in Q1 2026.
- Net Cash Flow for Q1 2026 came in at $950000.0, up 100.34% year-over-year; the trailing twelve-month figure through Mar 2026 was -$43.3 million (down 245.11% YoY), and the FY2025 annual result was -$320.8 million, down 226.32% from the prior year.
- Net Cash Flow slipped to $950000.0 in Q1 2026 per CNTA's latest filing, from $9.5 million in the prior quarter.
- Over five years, Net Cash Flow peaked at $269.6 million in Q3 2024 and troughed at -$276.5 million in Q1 2025.
- A 5-year average of -$31.4 million and a median of -$38.9 million in 2022 frame the typical range for Net Cash Flow.
- The sharpest annual moves came in 2024 and 2025: Net Cash Flow soared 934.45% in 2024, then plunged 2656.93% in 2025.
- A 5-year view of Net Cash Flow shows it stood at -$51.9 million in 2022, then climbed by 17.25% to -$43.0 million in 2023, then jumped by 65.47% to -$14.8 million in 2024, then jumped by 163.75% to $9.5 million in 2025, then slumped by 89.96% to $950000.0 in 2026.
- Business Quant data shows CNTA's Net Cash Flow at $950000.0 in Q1 2026, $9.5 million in Q4 2025, and $7.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 2.44 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 625.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.44 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 457.40 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 664,983.53 |
| 10 | Centessa Pharmaceuticals | 6.15 Bn | 6.15 Bn | - | 950,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 950,000.00 |
| Mar 31, 2026 | 950,000.00 |
| Dec 31, 2025 | 9.46 Mn |
| Dec 31, 2025 | 9.46 Mn |
| Sep 30, 2025 | 7.07 Mn |
| Sep 30, 2025 | 7.07 Mn |
| Jun 30, 2025 | -60.80 Mn |
| Jun 30, 2025 | -60.80 Mn |
| Mar 31, 2025 | -276.55 Mn |
| Mar 31, 2025 | -276.55 Mn |
| Dec 31, 2024 | -14.84 Mn |
| Dec 31, 2024 | -14.84 Mn |
| Sep 30, 2024 | 269.56 Mn |
| Sep 30, 2024 | 269.56 Mn |
| Jun 30, 2024 | 9.27 Mn |
| Jun 30, 2024 | 9.27 Mn |
| Mar 31, 2024 | -10.03 Mn |
| Mar 31, 2024 | -10.03 Mn |
| Dec 31, 2023 | -42.96 Mn |
| Dec 31, 2023 | -42.96 Mn |